Agilon Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . agilon health
AGL Stock  USD 0.59  0  0.47%   
Agilon Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Agilon Health's valuation are provided below:
Gross Profit
-160 M
Profit Margin
(0.07)
Market Capitalization
244.3 M
Enterprise Value Revenue
0.002
Revenue
5.9 B
There are over one hundred nineteen available fundamental signals for agilon health, which can be analyzed over time and compared to other ratios. We recommend to validate Agilon Health's prevailing fundamental drivers against the all of the trends between 2010 and 2026.

Agilon Health Total Revenue

3.49 Billion

Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 1 M, Interest Income of 8.5 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 0.0457, Dividend Yield of 0.0 or PTB Ratio of 2.36. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.
  
Build AI portfolio with Agilon Stock
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Agilon Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.3 B817.6 M
Slightly volatile
Short and Long Term Debt Total18.3 M19.2 M64.6 M
Slightly volatile
Total Current Liabilities717.2 M1.1 B416.3 M
Slightly volatile
Other Liabilities62.8 M66.1 M266.8 M
Slightly volatile
Property Plant And Equipment Net30 M25.4 M23 M
Slightly volatile
Accounts Payable1.4 B1.3 B458.7 M
Slightly volatile
Cash255.1 M173.7 M211.8 M
Slightly volatile
Non Current Assets Total233.6 M174.6 M184.4 M
Slightly volatile
Non Currrent Assets Other90 M83.5 M52.6 M
Slightly volatile
Other Assets83 M92.7 M50.6 M
Slightly volatile
Long Term Debt37.5 M31.4 M56.1 M
Slightly volatile
Cash And Short Term Investments526.2 M285.1 M293.4 M
Slightly volatile
Net Receivables574.7 M673.8 M298.3 M
Slightly volatile
Good Will23.4 M21.7 M35 M
Slightly volatile
Common Stock Total Equity3.6 M4.7 M3.1 M
Slightly volatile
Common Stock Shares Outstanding437.5 M414 M392.8 M
Slightly volatile
Long Term Debt Total37.5 M31.4 M56.1 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.3 B817.6 M
Slightly volatile
Non Current Liabilities Total64.7 M68.1 M319 M
Slightly volatile
Capital Surpluse1.6 B2.4 B881.4 M
Slightly volatile
Capital Lease Obligations8.9 M7.6 M7.9 M
Pretty Stable
Other Current Assets144.7 M137.8 M46.5 M
Slightly volatile
Other Stockholder Equity1.7 B2.1 B871.9 M
Slightly volatile
Total Liabilities943.6 M1.1 B744.8 M
Slightly volatile
Property Plant And Equipment Gross41 M70.9 M29.7 M
Slightly volatile
Short and Long Term Debt4.9 M7.2 M4 M
Slightly volatile
Total Current Assets1.2 B1.1 B633.2 M
Slightly volatile
Capital Stock3.9 M4.7 M3.1 M
Slightly volatile
Non Current Liabilities Other59.7 M62.6 M68.7 M
Pretty Stable
Cash And Equivalents275.1 M169.4 M213 M
Slightly volatile
Net Working Capital514.9 M351.6 M240.5 M
Slightly volatile
Short Term Debt20.2 M19.2 M5.8 M
Slightly volatile
Intangible Assets51.3 M65.7 M67.1 M
Slightly volatile
Common Stock4 M4.1 M3 M
Slightly volatile
Property Plant Equipment26 M42.5 M22.4 M
Slightly volatile
Long Term Investments74.6 M71 M21.7 M
Slightly volatile

Agilon Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income8.5 M10.1 M8.6 M
Pretty Stable
Depreciation And Amortization18 M28.6 M32.2 M
Slightly volatile
Interest Expense5.4 M6.6 M7.9 M
Slightly volatile
Selling General Administrative265.4 M238.5 M180 M
Slightly volatile
Total Revenue3.5 B5.9 B1.9 B
Slightly volatile
Other Operating Expenses3.7 B6.4 B2.1 B
Slightly volatile
Cost Of Revenue3.5 B6.1 B1.9 B
Slightly volatile
Total Operating Expenses278.4 M232.5 M192.1 M
Slightly volatile
Reconciled Depreciation17 M22 M31.7 M
Slightly volatile
Selling And Marketing Expenses150.4 K169.2 K184.7 K
Slightly volatile

Agilon Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation57.3 M49.1 M35.7 M
Slightly volatile
Begin Period Cash Flow351 M193.9 M193.5 M
Slightly volatile
Depreciation18 M28.6 M32.2 M
Slightly volatile
Capital Expenditures17.2 M13.2 M9.5 M
Slightly volatile
Change To Operating Activities84.5 M90.8 M57.8 M
Slightly volatile
Issuance Of Capital Stock997.8 K1.1 M179.8 M
Pretty Stable
End Period Cash Flow266.2 M173.7 M229.8 M
Slightly volatile
Change To Liabilities31.6 M61.9 M28.4 M
Slightly volatile
Change To Inventory194.3 M234.8 M166.5 M
Slightly volatile
Cash Flows Other Operating91.8 M105.8 M80.8 M
Slightly volatile
Dividends Paid5.5 M6.2 M6.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.04570.048110.0256
Slightly volatile
Days Sales Outstanding47.3441.454949.8325
Slightly volatile
Stock Based Compensation To Revenue0.00790.00830.0186
Pretty Stable
Capex To Depreciation0.70.46310.4488
Slightly volatile
EV To Sales0.02090.0229.9362
Slightly volatile
Payables Turnover3.64.744.2315
Slightly volatile
Sales General And Administrative To Revenue0.03820.04020.1303
Slightly volatile
Capex To Revenue0.00210.00220.0051
Very volatile
Cash Per Share0.970.68880.7254
Slightly volatile
Days Payables Outstanding89.9779.6886.3444
Slightly volatile
Income Quality0.260.27030.4408
Pretty Stable
Intangibles To Total Assets0.04910.05170.1945
Slightly volatile
Net Debt To EBITDA0.40.41881.0753
Pretty Stable
Current Ratio1.991.01881.5138
Slightly volatile
Receivables Turnover7.288.80477.6633
Slightly volatile
Capex Per Share0.0310.0320.0232
Slightly volatile
Revenue Per Share15.0514.3315.204
Slightly volatile
Interest Debt Per Share0.05940.06250.1871
Slightly volatile
Debt To Assets0.01440.01510.1325
Slightly volatile
Operating Cycle47.3441.454949.8325
Slightly volatile
Days Of Payables Outstanding89.9779.6886.3444
Slightly volatile
Ebt Per Ebit1.060.95971.027
Slightly volatile
Quick Ratio1.991.01881.5138
Slightly volatile
Net Income Per E B T1.421.00311.9211
Slightly volatile
Cash Ratio0.150.16140.648
Very volatile
Days Of Sales Outstanding47.3441.454949.8325
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.911.12521.0719
Slightly volatile
Fixed Asset Turnover24523381.9444
Slightly volatile
Debt Ratio0.01440.01510.1325
Slightly volatile
Price Sales Ratio0.04570.048110.0256
Slightly volatile
Asset Turnover4.94.66662.3741
Slightly volatile

Agilon Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap228.1 M256.6 M280.1 M
Slightly volatile
Enterprise Value104.5 M117.6 M128.3 M
Slightly volatile

Agilon Fundamental Market Drivers

Forward Price Earnings178.5714
Cash And Short Term Investments285.1 M

Agilon Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Agilon Health Financial Statements

Agilon Health investors utilize fundamental indicators, such as revenue or net income, to predict how Agilon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-873.8 M-917.5 M
Total Revenue5.9 B3.5 B
Cost Of Revenue6.1 B3.5 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.04  0.04 
Revenue Per Share 14.33  15.05 
Ebit Per Revenue(0.07)(0.07)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
How To Invest In Agilon
Details
Is Agilon Stock a good investment?
Details
What is Agilon Health's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Agilon Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
11.951
Earnings Share
(0.78)
Revenue Per Share
14.331
Quarterly Revenue Growth
0.031
Return On Assets
(0.18)
Investors evaluate agilon health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Agilon Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Agilon Health's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that Agilon Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agilon Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Agilon Health's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY